Uncategorized
Visioneering Expands Into Asia With Securing of Regulatory Registration in Hong Kong
ATLANTA--(BUSINESS WIRE)--US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘the Company’) is pleased to announce that it has received registration from Hong Kong’s Department of Health for its current and anticipated products. The registration covers the use of the Company’s NaturalVue Multifocal for myopia progression control. Visioneering sells patented revolutionary daily